- Apr 24, 2019
Air pollution poses risks for childhood cancer survivors
Poor air quality days significantly increase the risk of hospitalizations for respiratory issues in young survivors of cancer. Read more: https://medicalxpress.com/news/2019-04-air-pollution-poses-childhood-cancer.html
- Apr 24, 2019
Research Brief: Cancer rates in young children are increasing worldwide
Rates of pediatric cancer have been rising since the 1980s; however, this increase varies by age group and cancer type. University of Minnesota researchers studied children under 5 years of age to understand cancer trends that occur in this age group around the world. Read more: https://twin-cities.umn.edu/news-events/research-brief-cancer-rates-young-children-are-increasing-worldwide
- Apr 18, 2019
Why the Sisterhood of Mothers of Medically Fragile Children is the Best
We are a sisterhood that we never imagined being a part of and never wanted to be in this group. We are a sisterhood united in caring for our children and helping them meet their highest potential. Read more: https://www.patheos.com/blogs/withoutacrystalball/2018/08/11222
- Apr 17, 2019
Are you a researcher interested in childhood cancer?
The Cancer in Young People in Canada (CYP-C) Program maintains a national childhood cancer surveillance and research database that is available to researchers seeking to improve cancer diagnosis, treatment, and outcomes. Read more: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/contribute-research-childhood-cancer-infographic.html
- Apr 17, 2019
Mother seeks additional funding for childhood cancer research
London, Ont. mother Kim Vander Schelde is fighting for the Canadian government to increase the funding towards childhood cancer research. This comes after watching her young child battle cancer, while being treated with adult medication. View interview: https://globalnews.ca/video/5173487/mother-seeks-additional-funding-for-childhood-cancer-research
- Apr 16, 2019
Research finds new Rx target for childhood cancer
Research led by Michael Lan, Ph.D., Professor of Pediatrics and Genetics at LSU Health New Orleans School of Medicine, found that a compound named 5'-iodotubercidin (5'-IT) suppresses the growth of neuroblastoma cells and identified a potential new therapeutic approach for the disease. Read more: https://medicalxpress.com/news/2019-04-rx-childhood-cancer.html
- Apr 16, 2019
Which chemotherapy drugs have the highest cardiotoxicity risk in pediatric cancer?
A recent study published in JAMA Oncology analyzed data generated from over 28,000 childhood cancer survivors and compared the lifetime cardiotoxicity risk in different chemotherapeutic drugs used for treatment. Read more: https://www.medicalnewsbulletin.com/chemotherapy-drugs-highest-cardiotoxicity-risk-pediatric-cancer/
- Apr 16, 2019
Trial to assess novel targeted therapy for rare form of kidney cancer
A preclinical study that yielded new insights into a rare pediatric malignancy laid the foundation for a phase 2 trial that is evaluating a novel treatment approach in a specific type of kidney cancer. Read more: https://www.healio.com/hematology-oncology/genitourinary-cancer/news/online/%7Bcb9d14bb-4432-404c-8c94-cc7ca6b3c113%7D/trial-to-assess-novel-targeted-therapy-for-rare-form-of-kidney-cancer
- Apr 16, 2019
How Parents Use the Internet to Cope With a Child’s Cancer Diagnosis
Study results presented at the Oncology Nursing Society 44th Annual Congress described how parents use the Internet to build a support system. Read more: https://www.oncologynurseadvisor.com/uncategorized/how-parents-use-the-internet-to-cope-with-a-childs-cancer-diagnosis/
- Apr 10, 2019
Proton therapy shows efficacy, low toxicity in large cohort of children with high-risk neuroblastoma
Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric patients with high-risk neuroblastoma treated with proton radiation therapy (PRT), finding both that proton therapy was effective at reducing tumors and demonstrated minimal toxicity to surrounding organs. Read more: https://www.eurekalert.org/pub_releases/2019-04/chop-pts040919.php